substance p has been researched along with Epilepsy, Temporal Lobe in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bumanglag, AV; Burke, SN; Chun, E; Sloviter, RS | 1 |
Fujimiya, M; Hoshida, T; Matsuoka, H; Mochizuki, T; Naka, H; Sakagami, M; Takahashi, Y; Yoshioka, A | 1 |
Åhs, F; Appel, L; Danfors, T; Fredrikson, M; Furmark, T; Kumlien, E; Linnman, C | 1 |
de Lanerolle, NC; Eid, T; Kim, JH; Spencer, DD; Spencer, SS; Williamson, A; Zaveri, HP | 1 |
4 other study(ies) available for substance p and Epilepsy, Temporal Lobe
Article | Year |
---|---|
Targeted hippocampal GABA neuron ablation by Stable Substance P-saporin causes hippocampal sclerosis and chronic epilepsy in rats.
Topics: Animals; Chronic Disease; Dentate Gyrus; Epilepsy, Temporal Lobe; GABAergic Neurons; gamma-Aminobutyric Acid; Hippocampus; Male; Parvalbumins; Rats; Rats, Sprague-Dawley; Saporins; Sclerosis; Substance P | 2019 |
Intractable epilepsy: expression of substance P in cortical dysplastic neurons.
Topics: Child; Epilepsy, Temporal Lobe; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Malformations of Cortical Development; Microtubule-Associated Proteins; Neurons; Substance P | 2009 |
Increased neurokinin-1 receptor availability in temporal lobe epilepsy: a positron emission tomography study using [(11)C]GR205171.
Topics: Adult; Carbon Radioisotopes; Epilepsy, Temporal Lobe; Female; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Piperidines; Positron-Emission Tomography; Receptors, Neurokinin-1; Severity of Illness Index; Substance P; Temporal Lobe; Tetrazoles; Young Adult | 2011 |
A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories.
Topics: Adult; Apoptosis; Cell Count; Culture Techniques; Dentate Gyrus; Dynorphins; Electroencephalography; Epilepsy, Temporal Lobe; Evoked Potentials; Female; Follow-Up Studies; Hippocampus; Humans; Immunoenzyme Techniques; Interneurons; Male; Neurons; Neuropeptide Y; Reference Values; Retrospective Studies; Sclerosis; Somatostatin; Substance P; Treatment Outcome | 2003 |